JPMorgan Chase & Co. 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-16 09:34 am Purchase |
2025-06-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
JPMORGAN CHASE & CO JPM |
450,436 5.200% |
450,436 (New Position) |
Filing |